O3-14-5Analyses of CD204+ Macrophages in Allogeneic Stem Cell Transplantation for Malignant Lymphoma in Non-Remission

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy374.053
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Long-Term Clinical and Molecular Remission After Allogeneic Stem Cell Transplantation (SCT) in Patients With Poor Prognosis Non-Hodgkin's Lymphoma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphoma: A Nationwide Survey in Japan

Blood
BiochemistryImmunologyCell BiologyHematology
2006English

Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Remission and Relapse of Crohn's Disease Following Autologous Haematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Gut
Gastroenterology
2007English

Evaluation of Chimerism Dynamics After Allogeneic Hematopoietic Stem Cell Transplantation in Children With Non-Malignant Diseases.

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Allogeneic Stem Cell Transplantation for Sickle Cell Disease

Current Opinion in Hematology
Hematology
2016English

The Persistent Uncertainty of When to Recommend Allogeneic Stem Cell Transplantation in Follicular Lymphoma

Cancer
Cancer ResearchOncology
2018English

Allogeneic Hematopoietic Stem Cell Transplantation

Archives of Internal Medicine
2002English

Post-Transplant Lymphoproliferative Disorder in Patients With Lymphoma After Allogeneic Hematopoietic Stem Cell Transplantation

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy